https://www.live-feeds.com/feed/fda-announces-new-nationwide-blood-pressure-medication-recallContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/fda-announces-new-nationwide-blood-pressure-medication-recallhttps://www.live-feeds.com/feed/fda-announces-new-nationwide-blood-pressure-medication-recall#u89626Tue, 29 Sep 2026 21:56:37 +0000The FDA has announced a nationwide recall of over 13,000 bottles of chlorthalidone tablets, used to treat high blood pressure, due to failed dissolution testing. The recall is classified as Class II risk. Patients are advised to check their medication labels to see if their prescription is affected. The affected products failed to meet the agency's dissolution testing requirements.Why it mattersThis recall is the latest in a series of actions taken by the FDA to ensure the quality and safety of medications. Chlorthalidone tablets are used to treat hypertension and are commonly prescribed